AI Solutions for Neurovascular Pathologies

Despite improvements in primary care prevention and treatment, stroke is a devastating disease in the 21st century. Worldwide, stroke affects between 14 and 15 million people each year, meaning that 1 person out of 6 will suffer from a stroke in their lifetime. Stroke is a leading cause of long-term disability and the second leading cause of death, with one death every 6 seconds worldwide.

“Time is brain” is a well-known saying in the stroke community and, for stroke patients, every minute counts. There are two main types of strokes: ischemic stroke, caused by a blood clot, and hemorrhagic stroke, caused by an intracranial hemorrhage (bleeding inside the skull or brain).

Brain CT Scan Illustration

Fast Detection & Interpretation​

Our triage tools enable fast detection of disease, leading to more efficient patient management.

Neurovascular pathology icon

Reduce Error Rate & Misdiagnosis

By addressing radiologist data overload, stress, and fatigue, we help reduce medical errors and misinterpreted cases.

Patient in remission icon

Improve Quality of Care and Patient Outcome​s

Our tools facilitate decision making, ensuring a prompt therapeutic response and ultimately improving patient outcomes.

CINA-ICH

ce-marked-fda-cleared

Intracranial hemorrhages (ICH) affect over two million people worldwide with a 40-50% patient mortality rate within one month, and 80% disability despite aggressive care. Quick and accurate early diagnosis of ICH may facilitate a prompt therapeutic response, allow fast decision-making and ultimately improve outcomes. 

CINA-ICH uses deep learning to identify suspected intracranial hemorrhage and prioritizes those cases in the worklist, dramatically reducing turnaround time for head trauma and stroke patients.

Our solution helps healthcare providers to quickly and accurately identify ICH in order to facilitate decision making, ensure a prompt therapeutic response, and ultimately improve patient outcomes.

CINA-ICH
Results for CINA-ICH

CINA-LVO

ce-marked-fda-cleared

There are two types of acute ischemic strokes: small vessel occlusion (SVO) and large vessel occlusion (LVO). Ischemic stroke due to LVO accounts for around 80% of all strokes. For every 10 minutes delay, a patient will have a poorer disability outcome, so early diagnosis of LVO is of critical importance. 

CINA-LVO is a triage tool for neurovascular emergencies, designed to detect LVO of the anterior circulation (distal ICA, M1, or proximal M2) on CT angiographies of the head.

Providing rapid automatic LVO detection and real-time triage and prioritization, CINA-LVO leverages deep learning to help physicians’ workload, improve patient outcomes, accelerate diagnosis, and decrease the overall cost of care.

CINA-LVO
Results CINA-LVO

CINA-ASPECTS

ce-marked

Ischemic strokes may be treated with a mechanical thrombectomy and/or an intravenous thrombolysis (IVT). The IVT method has limitations regarding the size of the infarct, so a standardization of this quantification has been developed through the Alberta Stroke Program Early Computed Tomography Score (ASPECTS). 

ASPECTS is a topographic scoring system that divides the brain territory affected by the stroke into 10 areas of interest. The obtained score represents the ischemic changes for one of the two hemispheres (left or right). 

CINA-ASPECTS is an AI-based automatic quantification tool that enables faster, more consistent and more precise interpretation for the assessment of acute ischemic stroke. 

  • Provides a heat map indicating the probability of hypodensity and/or sulcal effacement in the brain
  • Outlines and displays the infarcted regions 
  • Displays a summary chart with mean Hounsfield Unit  per region
  • Provides the ASPECT score for  both  sides
CINA-ASPECTS
results cina aspects

CINA, medical images analysis software, is a medical device manufactured Avicenna.AI. This medical device is reserved for health professionals.

This software has been designed and manufactured according to the EN ISO 13485 Quality management system. Read the instructions in the notice carefully before any use.

Instructions for Use are available on https://avicenna.ai/

Manufacturer: Avicenna.AI (France). 

Medical devices Class I following European Medical Device Directive 93/42/CEE.

Medical devices Class II following the Code of Federal Regulations of the United States of America 21CFR on Medical Devices.

 

CINA-ASPECTS, medical images analysis software, is a medical device manufactured Avicenna.AI. This medical device is reserved for health professionals.

This software has been designed and manufactured according to the EN ISO 13485 Quality management system. Read the instructions in the notice carefully before any use.

Instructions for Use are available on https://avicenna.ai/

Manufacturer: Avicenna.AI (France). 

Medical devices Class I following European Medical Device Directive 93/42/CEE.

Partner with us!

We have built innovative technologies that change how AI is used. Partner with us, and let’s improve radiology together.

REQUEST A 30-DAY FREE TRIAL

features

Download

follow us

Linkedin Youtube Twitter
[zcwp id = 3]